Company Name: |
Jiangsu Vcare PharmaTech Co., Ltd.
|
Tel: |
025-58741518; 18013018875 |
Email: |
sales@vcarepharmatech.com |
Products Intro: |
Product Name:2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1S,3R,5S)- CAS:1564266-00-7
|
Company Name: |
Shanghai Kewel Chemical Co., Ltd.
|
Tel: |
021-64609169 18901607656 |
Email: |
greensnown@163.com |
Products Intro: |
Product Name:Saxagliptin Impurity 4(S,R,S,S-Isomer) CAS:1564266-00-7 Purity:95+ HPLC; Package:10mg;25mg;50mg;100mg
|
Company Name: |
Conier Chem & Pharma Limited
|
Tel: |
13368167990 |
Email: |
sales@conier.com |
Products Intro: |
Product Name:(S,R,S,S)-Saxagliptin HCl CAS:1564266-00-7
|
|
| 2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1S,3R,5S)- Basic information |
Product Name: | 2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1S,3R,5S)- | Synonyms: | 2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1S,3R,5S)-;Saxagliptin (S,R,S,S)-Isomer;(S,R,S,S)-Saxagliptin HCl;(1S,3R,5S)-2-[(2S)-2-amino-2-(3-hydroxy-1-adamantyl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile;Saxagliptin Impurity 4(S,R,S,S-Isomer);(2’S,2R,trans)-Saxagliptin;Saxagliptin Impurity 4 Hydrochloride (S,R,S,S-Isomer Hydrochloride);SaxagliptinS,R,S,S-Isomer Hydrochloride | CAS: | 1564266-00-7 | MF: | C18H25N3O2 | MW: | 315.41 | EINECS: | | Product Categories: | | Mol File: | 1564266-00-7.mol | |
| 2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1S,3R,5S)- Chemical Properties |
Boiling point | 548.7±35.0 °C(Predicted) | density | 1.35±0.1 g/cm3(Predicted) | pka | 15.12±0.40(Predicted) |
| 2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1S,3R,5S)- Usage And Synthesis |
Uses | (2’S,2R,trans)-Saxagliptin is an impurity of Saxagliptin (S143500); a potent and selective reversible inhibitor of dipeptidyl peptidase-4 (DPP-IV) developed for the treatment of type 2 diabetes. |
| 2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1S,3R,5S)- Preparation Products And Raw materials |
|